Natixis Partners advised Metex NØØVISTAGO, a European leader in animal nutrition and a subsidiary of METEX Group (METabolic EXplorer), in securing a senior financing for its investment plan.

NØØVISTAGO has more than 40 years of experience in the production of essential amino acids (lysine, tryptophan, valine, etc.) for animal nutrition. Based in Amiens, the site has a production capacity of more than 150 kt per year of amino acids, operated continuously by 300 employees. NØØVISTAGO is a leader in the European market and exports to customers in more than 60 countries. The site was acquired in 2021 by METEX, an innovative French bio-tech company specialized in the development and production by fermentation of natural functional ingredients, realizing a transforming operation by integrating an advanced industrial site of 7,000 sqm compatible with its production processes. METEX Group has activated its strategy to position NØØVISTAGO on high value-added segments through the industrialization of proprietary technologies (valine and glycolic acid) and other specialties, allowing to access the cosmetics and biopolymers markets. This debt raising operation will allow the Group to finance its investment plans corresponding to an amount of €70 million over four years, in addition to a €30 million revolving credit for general needs. The financing was syndicated with a banking pool including the Group's historical partners, consisting of Société Générale (Coordinator), Crédit du Nord/Banque Nuger, LCL, Crédit Agricole Brie-Picardie and Caisse d'Epargne et de Prévoyance Auvergne Limousin. This is the third transaction advised by Natixis Partners for METEX Group, following the acquisition of NØØVISTAGO site in 2020/21 and the Group's capital increase in 2021.